BlockBeats News, April 30th, according to official sources, the DePIN project Kairos has completed its seed round financing, led by Vertex Capital (UK), HKIFS (Hong Kong), and Oaktree Capital Management (US) jointly.
Kairos is focused on building a DePIN resource network for the AI Agent era, aiming to bridge the collaborative path between edge hardware and intelligent body computing. Its flagship product is the world's first mass-produced blood pressure monitoring smart ring, accompanied by a distributed health data computing ecosystem.
It is reported that Kairos has achieved the large-scale implementation of medical-grade sensor modules, and the core team has a background in chip design and manufacturing. The project's data encryption architecture complies with the HIPAA medical compliance standard, demonstrating strong hardware delivery capabilities and a foundation of data security. Additionally, Kairos holds multiple core technology patents, including dual-system monitoring of blood pressure/blood lipids (TW112130535, CN202310968656.1, US184494,804), multi-sign fusion algorithm (TW114102843, CN202510101010.2), world's smallest medical-grade sensor module (TW114200663, CN202520109894.1), early screening algorithm for Parkinson's disease (TW114101216, CN202510041020.1), and a passive CIS fluidic system derived from missile fuel monitoring technology.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.